Skip to main content
TipRanks
Go Ultimate75% OFF

Vanda (0LKB) Share Price & Analysis

0 Followers

0LKB Stock Chart & Stats

$3.80-$0.01(-0.13%)
At close: 4:30 PM GMT
$4$4.5$5$5.5Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$3.80 - $3.90
52-Week Range
$3.60 - $10.24
Previous Close
$3.81
Volume
N/A
Average Volume (3M)
7,219
Market Cap
$226.76M
Enterprise Value
$178.36M
Total Cash (Recent Filing)
$140.49M
Total Debt (Recent Filing)
$21.97M
Price to Earnings (P/E)
―
Beta
1.27
Next Earnings
Feb 10, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Fanapt Commercial Momentum

Fanapt is showing durable commercial traction following its bipolar I expansion, with higher sales, prescriptions, and new-to-brand demand. Continued volume growth and broader prescriber reach can support recurring revenue and help establish a stronger base before future exclusivity pressure emerges.

Protected BYSANTI Growth Opportunity

BYSANTI adds an approved product with a planned near-term launch and substantial stated exclusivity protection. Its indications overlap with Fanapt, creating an opportunity to build a durable commercial franchise while improving product continuity ahead of Fanapt's expected loss of exclusivity.

Low Balance-sheet Leverage

Very low leverage reduces fixed financial obligations and gives Vanda more balance-sheet flexibility than a highly indebted biotechnology company. This cushion can help support commercialization and development decisions, although its value depends on slowing losses and preserving available liquidity.

Bears Say

Severe Profitability Deterioration

The move from near-breakeven results in 2024 to heavy losses in 2025 and the TTM period indicates that revenue is not currently supporting the operating structure. Persistent negative margins can weaken internal funding capacity and make future growth increasingly dependent on cash reserves or external financing.

Accelerating Cash Burn

The sharp decline in cash resources, combined with management's expectation of higher full-year burn, raises a durable funding and runway concern. Continued spending on launches and development may consume liquidity before newer products generate meaningful revenue, limiting strategic flexibility.

HETLIOZ Generic Pressure

HETLIOZ is facing an established competitive erosion that has already reduced year-to-date sales, and management warned declines could become significant. This creates a persistent headwind for the existing revenue base and places greater pressure on Fanapt and pipeline launches to offset the shortfall.

Vanda News

0LKB FAQ

What was Vanda’s price range in the past 12 months?
Vanda lowest share price was $3.60 and its highest was $10.24 in the past 12 months.
What is Vanda’s market cap?
Vanda’s market cap is $226.76M.
When is Vanda’s upcoming earnings report date?
Vanda’s next earnings report is estimated for Feb 10, 2027 (not yet confirmed), which is in 83 days.
How were Vanda’s earnings last quarter?
Vanda released its earnings results on Oct 28, 2026. The company reported -$0.37 earnings per share for the quarter, beating the consensus estimate of -$0.682 by $0.312.
Is Vanda overvalued?
According to Wall Street analysts Vanda’s price is currently Undervalued.
Does Vanda pay dividends?
Vanda does not currently pay dividends.
What is Vanda’s EPS estimate?
Vanda’s EPS estimate is -0.30.
How many shares outstanding does Vanda have?
Vanda has 60,469,690 shares outstanding.
What happened to Vanda’s price movement after its last earnings report?
Vanda reported an EPS of -$0.37 in its last earnings report, beating expectations of -$0.682. Following the earnings report the stock price went up 3.333%.
Which hedge fund is a major shareholder of Vanda?
Hedge funds hold Vanda shares: the largest hedge-fund position in Vanda is 1,626,952,207 shares, and hedge funds decreased their holdings by 207.7K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology